| The potential impact of zinc supplementation on COVID-19 pathogenesis I Wessels, B Rolles, L Rink Frontiers in immunology 11, 563256, 2020 | 393 | 2020 |
| Zinc deficiency as a possible risk factor for increased susceptibility and severe progression of Corona Virus Disease 19 I Wessels, B Rolles, AJ Slusarenko, L Rink British journal of Nutrition 127 (2), 214-232, 2022 | 77 | 2022 |
| Influence of zinc deficiency and supplementation on NK cell cytotoxicity B Rolles, M Maywald, L Rink Journal of Functional Foods 48, 322-328, 2018 | 34 | 2018 |
| Comparable effects of the androgen derivatives danazol, oxymetholone and nandrolone on telomerase activity in human primary hematopoietic cells from patients with dyskeratosis … M Vieri, M Kirschner, M Tometten, A Abels, B Rolles, S Isfort, J Panse, ... International Journal of Molecular Sciences 21 (19), 7196, 2020 | 25 | 2020 |
| Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita M Kirschner, M Vieri, K Kricheldorf, MSV Ferreira, MW Wlodarski, ... British journal of haematology 193 (3), 669-673, 2021 | 24 | 2021 |
| Molecular pathogenesis of myeloproliferative neoplasms B Rolles, A Mullally Current Hematologic Malignancy Reports 17 (6), 319-329, 2022 | 18 | 2022 |
| Phosphatidylserine supplementation as a novel strategy for reducing myocardial infarct size and preventing adverse left ventricular remodeling D Schumacher, A Curaj, M Staudt, F Cordes, AR Dumitraşcu, B Rolles, ... International journal of molecular sciences 22 (9), 4401, 2021 | 16 | 2021 |
| The potential impact of zinc supplementation on COVID-19 pathogenesis. Front Immunol 11: 1712 I Wessels, B Rolles, L Rink | 14 | 2020 |
| The potential impact of zinc supplementation on COVID-19 pathogenesis. Front Immunol 2020; 11: 1712 I Wessels, B Rolles, L Rink PUBMED, 2020 | 13 | 2020 |
| The potential impact of zinc supplementation on COVID-19 pathogenesis, Front. Immunol. 11 (2020) 1712 I Wessels, B Rolles, L Rink | 11 | 2020 |
| CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response JS Jutzi, AE Marneth, MJ Jiménez-Santos, J Hem, A Guerra-Moreno, ... Leukemia 37 (2), 359-369, 2023 | 10 | 2023 |
| Intracellular zinc during cell activation and zinc deficiency B Rolles, M Maywald, L Rink Journal of Trace Elements in Medicine and Biology 68, 126864, 2021 | 10 | 2021 |
| DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation B Rolles, R Meyer, M Begemann, M Elbracht, E Jost, M Stelljes, I Kurth, ... Blood Cancer Journal 13 (1), 73, 2023 | 9 | 2023 |
| Telomere shortening in peripheral leukocytes is associated with poor survival in cancer patients treated with immune checkpoint inhibitor therapy B Rolles, J Gorgulho, M Tometten, C Roderburg, M Vieri, A Abels, ... Frontiers in Oncology 11, 729207, 2021 | 9 | 2021 |
| Impaired overall survival in young patients with acute myeloid leukemia and variants in genes predisposing for myeloid Malignancies M Kirschner, B Rolles, M Crysandt, C Röllig, F Stölzel, M Kramer, ... HemaSphere 6 (11), e787, 2022 | 4 | 2022 |
| Telomere biology disorders may manifest as common variable immunodeficiency (CVID) B Rolles, A Caballero-Oteyza, M Proietti, S Goldacker, K Warnatz, ... Clinical Immunology 257, 109837, 2023 | 2 | 2023 |
| Telomere length dynamics measured by flow-FISH in patients with obesity undergoing bariatric surgery B Rolles, MSV Ferreira, M Vieri, KP Rheinwalt, SM Schmitz, PH Alizai, ... Scientific Reports 13 (1), 304, 2023 | 2 | 2023 |
| Towards personalized medicine with iPS cell technology: a case report of advanced systemic mastocytosis with associated eosinophilia S Atakhanov, D Christen, B Rolles, HM Schüler, J Panse, N Chatain, ... Annals of Hematology 101 (11), 2533-2536, 2022 | 2 | 2022 |
| Inherited telomere biology disorders: pathophysiology, clinical presentation, diagnostics, and treatment B Rolles, M Tometten, R Meyer, M Kirschner, F Beier, TH Brümmendorf Transfusion Medicine and Hemotherapy 51 (5), 292-309, 2024 | 1 | 2024 |
| Clinical Implications of TP53 Mutations/Allelic State in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Treated with Hypomethylating Agents (HMA)-a Multicenter … T Kewan, JP Bewersdorf, O Blaha, M Stahl, NH Al Ali, AE DeZern, ... Blood 142, 1002, 2023 | 1 | 2023 |
